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ABSTRACT
Recently we reported that gene codon composition
determines differentiation-dependent expression
of the PV L1 genes in mouse primary keratinocytes
(KCs) in vitro and in vivo (Zhao et al. 2005, Mol. Cell
Biol. 25:8643–8655). Here, we investigated whether
generalized substitution of isoencoding codons
affects the duration of expression of PV L1 genes
in mouse and human KCs in day 1 culture transiently
transfected with native (Nat) and codon modified
(Mod) L1 genes. Following transient transfection,
KC continuously transcribed both Nat and Mod PV
L1 genes for at least 12 days, with the levels of
L1 mRNAs from the Mod L1 genes significantly
higher than those from the Nat L1 genes. However,
continuous L1 protein expression at day 9 post-
transfection was observed for both mouse and
human KCs transfected with the Nat L1 genes
only. Further, aa-tRNAs prepared from D8 KC
cultures enhanced translation of two PV Nat L1
DNAs in RRL lysate and PV Nat L1 mRNAs in D0
cell-free lysate, whereas aa-tRNAs from D0 KCs
enhanced translation of PV Mod L1 mRNAs in D8
cell-free lysate. It appears that aa-tRNAs in less-
differentiated and differentiated KCs differentially
match the PV Nat and Mod L1 mRNAs to regulate
their translations in vitro.
INTRODUCTION
The standard version of the genetic code includes 61 sense
codons and 3 stop codons. The 61 sense codons in an
mRNA molecular are translated to code 20 amino acids
in the course of protein synthesis. Except for methionine
and tryptophan, the 18 most common amino acids are
coded by two to six codons called synonymous codons.
Previous studies have clearly indicated that synonymous
codons are used with unequal frequency in a protein-
coding sequence and choice of the synonymous codons
is far from random both within and between organisms
(1–3). Consequently, the patterns of codon usage vary
considerably among organisms, and also among genes
from the same genome (4). Codon usage has been known
to present a potential impediment to high-level gene
expression in Escherichia coli and yeast (5,6). In humans,
codon-mediated translational controls may play an
important role in the diﬀerentiation and regulation of
tissue-speciﬁc gene products (7).
Virus genomes frequently have their codon usage
signiﬁcantly diﬀerent from their host species (8,9). We
observed that papillomaviruses (PVs), like many mamma-
lian DNA viruses, have a signiﬁcantly greater usage of
codons with third position of A/T, manifesting a A+T
rich genome (10). Meanwhile, PV late (L1 and L2) genes
frequently use the codons such as UUG, CGU, ACA and
AUU that are rarely used in mammalian genes (10,11).
Thus, when PV L1 and L2 genes are transfected into a
wide range of eukaryotic cells, large amounts of the
mRNAs can be transcribed, but no protein product is
detected (12), which indicates that expression of the late
genes is subject to post-transcriptional regulation (13).
In HPVs, generalized substitution of isoencoding codons
(mammalian preferred codons) with a higher G+C
content allows expression of L1 and L2 proteins in
diﬀerent types of eukaryotic cells in vitro (10,14–17). The
poor expression of several viral and other proteins has
also been attributed to the unfavourable codon usage
of their genes (18–20). The codon usage of the native GFP
gene is not adapted to mammalian ‘consensus’ and
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unmodiﬁed GFP is poorly expressed in mammalian
systems(18,21). Modiﬁcation of the codon usage of HIV-
1 genes to those used by highly expressed human genes has
been found to signiﬁcantly increase HIV-1 structural
protein expression (22).
It is clear now that expression of hetero genes at
translational levels can be signiﬁcantly increased by
synonymous codon substitution (18–20). However, we
observed that the eﬀects of synonymous codon substitu-
tion on translation of the PV L1 mRNAs in the KC
cultures were dependent on the cell diﬀerentiation (23).
In our study, the transiently transfection assay of the PV
L1 gene expression in KC cultures was conducted at 48 h
post-transfection as expression of a targeted gene has been
generally overlooked in favour of early time points
in other studies (24,25). In a recent study, we observed
that hm gfp variants in which were introduced with
diﬀerent sets of six consecutive codons down stream the
AUG codon show diﬀerent mRNA translation eﬃciency
and have diﬀerent duration of the GFP expression in
transiently GFP plasmids-transfected mammalian cells.
(10,26). Thus, it is possible that generalized substitution
of synonymous codons may improve not only the
translation eﬃciency of the viral genes, but also change
the duration of its expression in KCs post-transfection. In
this article, we address the following issues: (i) how long
expression of the PV L1 genes can be detected in primary
mouse and human KC cultures following transient
transfection of the Nat and Mod PV L1 gene expression
constructs; (ii) whether generalized substitution of
isoencoding codons aﬀects the duration of the L1 gene
expression due to cell diﬀerentiation; (iii) if cell-free lysates
prepared from the mouse KC cultures can be used for
translation of both Nat and Mod PV L1 mRNAs
in vitro and (iv) whether supplementation of exogenous
aa-tRNAs aﬀects expression of Nat and Mod L1 DNAs
and mRNAs in diﬀerent cell-free in vitro translation
systems.
MATERIALS AND METHODS
Plasmid construction and preparation
The four PV L1 gene expression plasmids: pCDNA3
NatHPV6b L1, pCDNA3Mod HPV6b L1, pCDNA3 Nat
BPV1 L1 and pCDNA3 Mod BPV1 L1 used in the
experiments have previously been described (10,15).
Brieﬂy, both BPV1 and HPV6b wt L1 ORFs are
approximately 1.5 kb in length encoding 500 amino
acids. The PV wt L1 genes show a strong codon usage
bias, amongst degenerately encoded amino acids, toward
18 codons mainly with T at the third position that are
otherwise rarely used by mammalian genes (10,11). We
artiﬁcially modiﬁed BPV1 and HPV6b L1 genes such that
the L1 ORFs were substituted with codons having G or C
at the third position, which are preferentially used in the
mammalian genome (10). All of the native and codon
modiﬁed PV L1 ORFs were sequenced and cloned into the
mammalian expression vector pCDNA3, which contains
the simian virus 40 (SV40) ori (Invitrogen, Australia),
to give four expression plasmids pCDNA3HPV6b Nat L1,
pCDNA3HPV6b Mod L1, pCDNA3BPV1 Nat L1 and
pCDNA3BPV1 Mod L1. Correct orientation of the
ORFs relative to the plasmids was conﬁrmed by enzyme
restriction analysis. All the PV L1 constructs were
sequenced to conﬁrm the desired sequences before use.
Primarymouse and humanKC culture andDNA transfection
Mouse KCs were isolated from new born mouse skin as
originally described (27) with some modiﬁcations. Brieﬂy,
isolated KCs were grown as adherent cultures at a density
of 6.5 104 cells/cm2 in freshly prepared 3:1 medium as
previously described (23) for one day. The KC cultures
were then transfected with the PV L1 gene expression
constructs (pCDNA3 Nat HPV6b L1, pCDNA3 Mod
HPV6b L1, pCDNA3 Nat BPV1 L1 and pCDNA3 Mod
BPV1 L1) (10,28) using lipofectamine (Invitrogen,
Australia) according to the manufacturer’s protocol with
some modiﬁcations. Following transfection, the DNA-
transfected KCs continued to grow in KC-SFM medium
with low calcium (0.09mM) and was collected for RNA
and protein preparation at days 3 (D3), 6 (D6), 9 (D9) and
12 (D12) post-transfection.
Human KCs isolated from neonatal foreskins were
cultured in KC serum-free medium (Life Technologies,
Australia) up to conﬂuence. The KCs were then passaged
at a density of 6.5 104 cells/cm2. After one day, the
human KCs were transfected with the four PV L1 gene
expression constructs as described above. Following
transfection, the DNA-transfected KCs continued to
grow in KC-SFM medium with low calcium (0.09mM)
and collected for RNA and protein preparation at days
3 (D3), 6 (D6) and 9 (D9) post-transfection.
Quantitative reverse-transcriptase PCR (RT-PCR)
Here. 0.5mg of RNA puriﬁed from cultured KCs
transfected with the diﬀerent PV L1 gene expression
constructs was converted to complementary DNA using
Oligo-dT primers and PowerScript reverse transcriptase
(Promega, Australia) according to the manufacturer’s
protocol. We used 50 ng of each cDNA sample in 20 ml
RT-PCR reactions using a Promega kit (Promega,
Australia) supplemented with 3mM MgCl2 and
Platinum Taq Polymerase (Invitrogen, Australia).
RT-PCR was undertaken using the Taqman system
(AB Applied Biosystems, Australia).
Protein preparation andWestern blot analysis
The L1-DNA-transfected KCs were lysed in cell lysis
buﬀer containing 2mM of PMSF and sonicated for 40 s.
Forty microgram (40 mg) protein samples from whole-cell
extracts were separated by SDS-PAGE and blotted onto
PVDF membrane. The blots were ﬁrst probed with
monoclonal antibody (29) against PV L1 protein, and
then incubated with horseradish peroxidase-conjugated
goat anti-mouse IgG antibody (Sigma, Australia).
A chemiluminescence system (ECL kit; Amersham,
Australia) was used to visualize the L1 signals. After
probing for the L1 protein, the blots were stripped and
relabeled with antibody against b-tubulin.
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De novo Synthesis of L1 and cellular proteins
De novo synthesis of the PV L1 proteins in cultured mouse
KCs was studied by labeling with [35S]-methionine.
KCs cultured in six-well plates for one day (D1) were
transfected with the PV L1 gene expression constructs
(pCDNA3 Nat HPV6b L1, pCDNA3 Mod HPV6b L1,
pCDNA3 Nat BPV1 L1 and pCDNA3 Mod BPV1 L1)
using lipofectamine (Invitrogen, Australia) as previously
described (23). After transfection, L1 gene-transfected
KCs continued to be grown in KC-SFM medium and at
D2, D5 and D8 post-transfection were incubated in 2ml
of medium supplemented with 10 mCi of L-[35S]Met
(370 kBq) overnight. L1 gene-transfected KCs labelled
with [35S]-methionine at D3, D6 and D9 post-transfection
were collected for protein analysis. Forty microgram
(40mg) protein samples, each in 1ml of immunoprecipita-
tion buﬀer (50mM Tris, pH 8.0, 150mM NaCl, 1%
Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS,
1mM phenylmethane sulphonyl ﬂuoride (PMSF) (Sigma,
Australia), 2 mg/ml benzamidine (Sigma, Australia), apro-
tinin 2 mg/ml and 1 mg/ml leupeptin (Auspep, Australia))
were immunoprecipitated using antibody against the
L1 protein and then separated by SDS-PAGE. The
SDS-PAGE gel was dried and autoradiographed.
Synthesis of two cellular proteins involucrin and tubulin
in mouse KC cultures over time were also examined.
Immunofluorescence labeling
In parallel experiments, intracellular localization of the
PV L1 proteins in mouse KC cultures were examined.
KCs cultured for one day were transfected with each of the
four PV L1 plasmids, and then ﬁxed and permeabilized
with 85% ethanol at 3 and 9 day post-transfection. The
ﬁxed KCs were then blocked with 5% skim milk-PBS,
probed with monoclonal antibody against the PV L1
protein, and followed by Cy3-conjugated anti-mouse
immunoglobulin G (IgG) (Sigma, Australia). The L1
labeled KCs were further blocked with 5% skim milk
PBS and probed with polyclonal antibody against
involucrin (Sigma, Australia), followed by FITC secondary
antibody. Nuclei were countstained by 40,60-diamidino-2-
phenylindole (DAPI). Antibody-labeled KCs were
examined by immunoﬂuorescence microscopy.
Cell-free in vitro translation of PV L1 plasmid DNAs
in RRL system
One microgram of each plasmid DNA was incubated with
10 mCi of [35S]methionine (Amersham, Australia) and 20 ml
of T7 DNA-polymerase-coupled rabbit reticulocyte
lysates (RRL) (Promega, Australia), with or without
additional aa-tRNAs as indicated. Translation was
performed at 308C from 15 to 45min and stopped by
adding 2 SDS sample loading buﬀer. The L1 proteins
were separated by SDS-PAGE on a 10% gel and blotted
onto PVDF membrane. The blots were imaged using
a phosphor screen and quantiﬁed by PhosphorImager
analysis using the Imagequant program (Molecular
Dynamics, USA).
Preparation of KC cell-free lysate for in vitro translation
of the PV L1mRNAs
Cell-free lysate was prepared from the mouse primary
KCs cultured for one, three and eight days as described
previously (30) with some modiﬁcations. Brieﬂy, the
cultured KCs were scraped into an extraction buﬀer
containing 100mM Hepes-KOH (pH 7.4), 120mM
potassium acetate (pH 7.4), 2.5mM magnesium acetate,
1mM dithiotreitol, 2.5mM ATP, 1mM GTP, 100 mM
S-adenosyl-methionine, 1mM spermidine, 20mM creatine
phosphate, 40 U of creatine phosphokinase (Sigma,
Australia) per ml, and, importantly, an additional
100mM sucrose. The collected KCs were then passed
through a 25-gauge needle ten times, and the lysate was
centrifuged at 48C and 100 g for 2min. The supernatant
was collected to prepare the mRNA-dependent KC
cell-free lysate. The endogenous mRNAs in the prepared
KC cell-free lysate were hydrolysed by incubating the
lysate at 208C for 10min in the presence of 10 U/per ml of
micrococcal nuclease (31) and 1mM CaCl2. The enzyme
was inhibited by adding 2.5mM ethylene glycol-bis
(b-aminoethyl ether)-N,N,N0,N0-tetraacetic acid (EGTA,
pH 7.0). The cell-free lysate was supplemented with
0.02mM hemin before use.
In vitro translation of the PV L1mRNAs in KC cell-free
lysate system
In vitro transcription. The four PV L1 gene expression
plasmids: pCDNA3 HPV6b Nat L1, pCDNA3 HPV6b
Mod L1, pCDNA3 BPV1 Nat L1 and pCDNA3 BPV1
Mod L1 were linearized with EcoRI and transcribed by T7
RNA polymerase (Promega, Australia) at 378C for 3 h.
The transcription reaction contained 5mM m7 GpppG to
synthesize capped PV L1 mRNAs. Following transcrip-
tion, 2 ml RNase-free DNase (2000 U/ml, Promega,
Australia) was added into each reaction to digest the
DNA template at 378C for 1 h. The transcribed PV L1
mRNAs were then puriﬁed by phenol–chloroform extrac-
tion, followed by precipitation with 2 volumes of ethanol
and washed twice with 70% ethanol. The puriﬁed PV L1
mRNAs resuspended in RNase-free water were used for
in vitro translation.
In vitro translation. The in vitro translation mixture
consisted of 17.5ml KC cell-free lysate, 2 ml PV L1
mRNA (1 mg per reaction), 0.5ml RNase inhibitor, 0.5 ml
amino acid mixture (1mM each amino acid) and 4.5 ml
RNase-free H2O. Translation reaction was carried out at
308C for 1–3 h. The reactions were stopped with the
addition of 2 SDS-sample buﬀer and then denatured at
808C for 10min. The translated PV L1 proteins were
analysed by SDS-PAGE and blotted on PVDF mem-
brane. The blots were examined for the PV L1 proteins by
immunoblotting analysis using the monoclonal antibody
against L1 proteins as mentioned above. The L1 signals
were quantiﬁed by densitometric analysis using the
Imagequant program (Molecular Dynamics, USA).
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Preparation of aa-tRNAs for in vitro translation
Total tRNAs were extracted and puriﬁed from KC
cultures using a Qiagen kit as instructed by the supplier
(17). aa-tRNAs were produced for addition to either RRL
system or KC lysate system as previously described (10).
tRNAs (2.5 105M) puriﬁed from D0 and D8 mouse
and human KC cultures were added to a 50 ml reaction
mixture containing 10mM Tris-acetate (pH 7.8), 44mM
KCl, 12mM MgCl2, 9mM b-mercaptoethanol, 38mM
ATP, 0.25mM GTP and 15 ml of rabbit reticulocyte
extract. The reaction was carried out at 258C for 20min
and 30 ml of H2O was then added to the reaction to dilute
the tRNAs to 105M. The aa-tRNAs were aliquoted and
stored at 708C for later use.
RESULTS
Codon modification alters continuous expression patterns
of the PV L1 genes in both mouse and human KCs
Recently, we reported that expression of the PV L1
proteins from Nat PV L1 genes is only detected in
diﬀerentiated KCs and that the codon composition of
the Nat L1 genes determines the diﬀerentiation-dependent
expression of the L1 proteins (23). Here, we have
examined whether continuous expression of L1 protein,
as observed in vivo, can be recapitulated in vitro and how
the gene codon composition mediates the continuous
expression of the L1 genes. We transiently transfected
mouse KCs that had been cultured for one day (D1
cultured KCs) with the PV Nat and Mod L1 gene
expression constructs. The L1-tranfected mouse KCs
were collected for RNA and protein preparation at D3,
D6, D9 and D12 post-transfection. Progressive changes of
the cell morphology of the L1-transfected mouse KCs
from D3 to D12 post-transfection were examined by light
microscopy (data not shown). The morphological changes
observed for the L1-transfected KCs over time reﬂected
cell diﬀerentiation that was conﬁrmed by the increased
expression of involucrin that is a marker of keratinocyte
terminal diﬀerentiation (32,33) using immunoﬂuorescence
microscopy (Figure 1) and [35S]-methionine labeling
experiments. We have also used immunoﬂuorescence
microscopy to investigate whether and how the L1
proteins encoded by the HPV6b Nat and Mod L1 genes
were expressed in the L1-transfected KCs at D3 and D9
post-transfection (Figure 1). The L1 protein expressed
from the Nat L1 gene was detected in the L1-transfected
KCs at both D3 and D9, but from the Mod L1 genes only
at D3 post-transfection (Figure 1). Meantime, expression
of involucrin in L1-transfected KCs at both D3 and D9
post-transfection was examined (Figure 1). 20–30% of the
L1-transfected KCs at D3 post-transfection exhibited
weak involucrin signal, while all the L1-transfected KCs
at D9 post-transfection had strong involucrin expression,
suggesting that they proceed cell diﬀerentiation. (Figure 1).
The transcripts of both Nat and Mod PV L1 genes were
then analysed by quantitative RT-PCR. Gel electrophor-
esis revealed that the L1 mRNAs can be detected in
KCs up to 12 days post-transfection (Figure 2A). Given
that the reported half life of the PV L1 mRNAs was
approximately 5 h in mammalian cells (34) and mouse
KCs (23), the results suggest that the cultured KCs can
continuously transcribe the transiently transfected PV
L1 genes over the time period examined. Quantitative
RT-PCR analysis revealed that transcription of both Nat
and Mod PV L1 genes was distinctly down-regulated
in the L1-transfected KCs as the cell diﬀerentiated.
Meantime, the levels of L1 mRNAs from the Mod L1
genes were signiﬁcantly higher than those from the Nat L1
genes over the time course (Figure 2B), suggesting that
replacement of the GC- ending codons in the PV L1 genes
can improve their transcription eﬃciencies in KCs. In
contrast, western blot analysis showed that the detected
signals of the L1 proteins expressed from the two PV Nat
L1 genes increased signiﬁcantly over time, with the highest
levels of the L1 proteins detected at D9 post-transfection
(Figure 2B). Steady expression of the L1 proteins from the
two PV Mod L1 genes was detected at D3 and D6
(Figure 1B) after which expression of the L1 proteins
decreased dramatically and was not detectable in the
HPV6bMod L1 transfected KCs at D12 post-transfection
(Figure 2B). The results suggest that the PV L1 proteins
can be continuously detected in L1-transfected KCs for
L1
D
9
D
3
Involucrin Nucleus Merger 
HPV6b  NatL1 HPV6b Mod L1 
L1  Involucrin Nucleus Merger 
Figure 1. Expression of the HPV6b L1 protein in individual KCs. Mouse KCs grown in medium for 1 day were transfected with an expression
construct for a HPV6b Nat or Mod L1 gene as indicated. At 3 and 9 days post-transfection, the KCs were stained by indirect immunoﬂuorescence
for HPV6b L1 protein (red) and for involucrin (green), and nuclei counterstained with DAPI (blue). Merger panes combine all three images.
All pictures 400.
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a certain period, and that codon composition of the L1
mRNA plays a key role in regulation of the continuous
expression of the L1 proteins.
Considering that human KCs are the host cells of HPV
infection, we also investigated the expression of the four
PV L1 gene expression constructs in primary human KC
culture. Both L1 mRNA transcription examined by
quantitative RT-PCR and protein expression analysed
by western blot were investigated. Similar results were
obtained (Figure 3A and B). Thus, the data produced
from both mouse and human primary KCs suggest that
the continuous expression of the PV L1 proteins is also
post-transcriptionally regulated and associated with cell
diﬀerentiation.
Synthesis of the PV L1 proteins from the PVModL1 genes
diminishes with time in cultured KCs
To investigate whether the PV L1 proteins contin-
uously detected from both Nat and Mod L1 genes in
L1-transfected KCs over the time course are due to
continuous synthesis of the L1 proteins, rather than their
intrinsic stability in cultured KCs. The L1-transfected
mouse KCs maintained in normal KC medium were
labeled overnight with [35S]-methionine at D2, D5 and D8
post-transfection, respectively. The extended labeling time
is required to incorporate suﬃcient radioactivity into the
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Figure 3. Time course assay for continuous expression of both Nat and
Mod PV L1 genes in cultured human KCs. KCs at a density of
6.5 104 cells/cm2 in medium grown for 1 day were transiently
transfected with the four L1 gene expression constructs for 16 h and
then collected for analysis of the L1 gene expression for a 9-day period
post-transfection. (A) Quantitative RT-PCR analysis of L1 mRNA in
cultured KC cells. RNA samples were prepared at D3, D6 and D9
post-transfection. 0.5 mg of each sample of DNase I-digested total RNA
was used for RT-PCR. Upper panel: The RT-PCR products from L1
and actin mRNAs were electrophoresed on a 1% agarose gel. Lower
panel: Relative L1 mRNAs are shown with the means ( S.E.M) of
four separate assays from two separate transfections. Statistical analysis
of the results was conducted. P50.01 and P50.05 represent the
signiﬁcant degree of the diﬀerences between Nat and Mod L1 mRNAs
using t Test, respectively. (B) Western blotting analysis of L1 protein
and b-tubulin in cultured human KCs. Monoclonal antibody against
L1 protein was used to probe the blot. Upper panel shows the results
of the L1 immunoblotting assay; lower panel shows the signals of
b-tubulin showing comparable loading of the protein samples.
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Figure 2. Time course assay for continuous expression of both Nat and
Mod PV L1 genes in cultured mouse KCs. Mouse KCs grown in
medium for 1 day were transiently transfected with the four L1 gene
expression constructs for 16 h and then collected for analysis of the L1
gene expression for a 12-day period post-transfection. (A) Quantitative
RT-PCR analysis of L1 mRNA in cultured KC cells. RNA samples
were prepared at D3, D6, D9 and D12 post-transfection. 0.5 mg of each
sample of DNase I-digested total RNA was used for RT-PCR. Upper
panel: The RT-PCR products from L1 and actin mRNAs were
electrophoresed on a 1% agarose gel. Lower panel: Relative L1
mRNAs are shown with the means ( S.E.M) of four separate
assays from two independent experiments. Statistical analysis of the
results was conducted. P50.01 and P50.05 represent the signiﬁcant
degree of the diﬀerences between Nat and Mod L1 mRNAs using
t Test, respectively. (B) Western blotting analysis of L1 protein and
b-tubulin in cultured mouse KCs. Monoclonal antibody against L1
protein was used to probe the blot. Upper panel shows the results
of the L1 immunoblotting assay; lower panel shows the signals of
b-tubulin showing comparable loading of the protein samples.
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newly synthesized proteins to be detected. Following
[35S]-methionine labeling, the L1-transfected KCs were
collected at D3, D6 and D9 post-transfection and
analysed for the synthesis of involucrin, b-tubulin and
L1 protein (Figure 4A and B). Immunoprecipitation of
the methionine-labeled involucrin and b-tubulin showed
that the level of methionine-labeled involucrin steadily
increased in cultured KCs over time accompanied by
a slight decrease of the b-tubulin synthesis observed in
the D9 KC culture (Figure 4A). The increasing expression
of the involucrin over time reﬂects the L1-transfected KC
cultures’ proceeding cell diﬀerentiation.
Immunoprecipitation of the methionine-labeled L1
proteins showed levels of the newly synthesized L1
proteins expressed from the two PV Nat L1 genes were
low at D3 (Figure 4B), but were signiﬁcantly up-regulated
at D9. In contrast, the L1 protein synthesis in the KCs
transfected with the two PVMod L1 expression constructs
was active at D3 post-transfection (Figure 4B). The
synthesis of the L1 protein by the HPV6b Mod L1
expression construct was active in the L1-transfected
KCs at D6, but not detectable at D9 post-transfection
(Figure 4B). The L1 protein synthesis in the KCs
transfected with the BPV1 Mod L1 expression constructs
was signiﬁcantly down-regulated from D3 to D9 post-
transfection. To compare the relative levels of the newly
synthesized L1 proteins from the PV Nat L1 gene
expression constructs to those from the PV Mod L1 gene
expression constructs over the time course, we examined
the ratio of the newly synthesized L1 protein to the tubulin
(L1/tubulin) by densitometric analysis of L1 protein and
b-tubulin signals (Figure 4C). The ratios of the L1/tubulin
produced from the PV L Nat 1-transfected KCs were
0.66 0.15 for HPV6b and 0.66 0.04 for BPV1 at D3
post-transfection and 0.92 0.25 for HPV6b and
0.76 0.01 for BPV1 at D6 post-transfection, but were
signiﬁcantly increased up to 1.65 0.16 for HPV 6b and
1.75 0.55 for BPV1 at D9 post-transfection. In contrast,
the ratios of the L1/tubulin produced from the Mod
PV L1-transfected KCs were 1.70 0.02 for HPV 6b and
1.34 0.03 for BPV1 at D3 post-transfection and
1.87 0.39 for HPV 6b and 0.82 0.05 for BPV1 at D6
post-transfection, but were signiﬁcantly decreased to
0.09 0.01 for HPV 6b and 0.29 0.02 for BPV1 at D9
post-transfection. The ratios between PV Nat L1/tubulin
and PV Mod L1/tubulin were signiﬁcantly diﬀerent
over the time course, except for BPV1 L1 at D6 post-
transfection (Figure 4C). The data suggest that the
detected continuous expression of the L1 proteins from
the PV L1 genes (Figure 4C) was due to the continuous
synthesis of the L1 proteins and that codon composition
of the L1 mRNA sequences was a major determinant of
the continuous synthesis of the L1 proteins.
aa-tRNAs fromD8mouse KC cultures enhance translation
of the PVNat L1 genes in RRL translation system
Recently, we showed that translation of L1 from PV
Nat L1 genes in a RRL cell-free translation system was
preferentially enhanced by aa-tRNAs from diﬀerentiated
KCs in vivo (23). Here, we have examined whether and
how aa-tRNAs prepared from the mouse KCs cultured for
one (D0) or eight (D8) days aﬀect translation of L1
proteins from Nat L1 genes in the RRL cell-free
translation system. We showed that translation of the L1
proteins from PV Nat L1 genes was much slower than
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Figure 4. Continuous synthesis of L1 proteins studied by labeling with
[35S]-methionine. Cultured mouse KCs at D1 were transiently
transfected with 2 mg of the PV L1 gene constructs for 16 h. The PV
L1 gene-transfected KCs were then incubated in 2ml normal KC
culture medium labeled with 10 mCi of L-[35S]Met (370 kBq) at D2, D5
and D8 post-transfection. Protein samples were collected for analysis of
L1 protein and b-tubulin incorporated with [35S]-methionine at D3, D6
and D9 post-transfection. Forty mg protein samples, in 1ml of
immunoprecipitation buﬀer (50mM Tris, pH 8.0, 150mM NaCl, 1%
Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS with protease
inhibitors and phosphatase inhibitors), were immunoprecipitated by
monoclonal antibodies against either L1 protein or b-tubulin or by
polyclonal antibody against involucrin, separated by SDS-PAGE and
autoradiographed for 48 h. (A) The results of both involucrin and
b-tubulin synthesis are representative of two independent experiments.
(B) The results of both L1 and b-tubulin synthesis are representative of
two independent experiments. (C). Ratio of synthesized L1 protein
to b-tubulin (L1/tubulin) was examined by densitometric analysis of
L1 protein and b-tubulin signals from two independent experiments.
Statistical analysis between Nat L1/tubulin and Mod L1/tubulin
at individual time points was conducted using paired t test. P50.05
or P50.01 was compared between Nat L1/tubulin and Mod L1/tubulin
as shown.
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that from the PV Mod L1 genes over a time course
of 15–45min (Figure 5A). Supplementation of the
aa-tRNAs from D0 or D8 KCs had no distinct eﬀects
on the translation of the Mod L1 genes (Figure 5B).
In contrast, introduction of exogenous aa-tRNAs from
D0 KCs did not enhance translation of PV Nat L1 genes,
but addition of exogenous aa-tRNAs from D8 KCs
signiﬁcantly enhanced translation of Nat PV L1 genes in
a dose-dependent manner with optimum eﬃciency at
107M (Figure 5C). Addition of 107M aa-tRNA from
D8 cultured KCs produced strong L1 bands from both PV
L1 genes at 15min, while the corresponding L1 bands
from the control reactions without added aa-tRNAs were
weak (Figure 5C). It was observed that 107M aa-tRNAs
from D8 cultured KCs gave enhanced translation of
L1, 1.59 0.6-fold for HPV6b and 2.09 0.8 for BPV1
(Figure 5C, lower panel). The results suggest that the
improved translation of native L1 mRNA and inhibition
of the translation of codon modiﬁed L1 mRNA in diﬀer-
entiated epithelial cells is probably due to an association
of gene codons with the cellular aa-tRNAs as the tRNA
gel proﬁles were diﬀerent between D0 and D8 cultured
KCs (unpublished data).
aa-tRNAs fromD0 and D8 human KC cultures differentially
enhance translation of the PVMod andNat L1 genes in
RRL translation system
To prove that aa-tRNAs from the human KCs would
have similar eﬀects, we have examined further how the
tRNAs (107M) prepared from both D0 and D8 human
KC cultures aﬀected translation of the L1 proteins from
the PV Nat and Mod L1 genes in the RRL cell-free
translation system. Again, introduction of exogenous
107M aa-tRNAs from D8 human KCs dramatically
increased the production of L1 protein from the two PV
Nat L1 gene constructs while they had few eﬀects on
expression of the two PV Mod L1 genes (Figure 6B).
Surprisingly, supplementation of 107M aa-tRNAs from
D0 human KCs could signiﬁcantly enhance translation of
the two PV Mod L1 genes, but not of the two PV Nat L1
genes (Figure 6A). The results indicate that aa-tRNAs
from D0 and D8 human KC cultures diﬀerentially
enhance translation of the PV Mod and Nat L1 genes in
RRL translation system.
In vitro translation of the PVNat andMod L1
mRNAs differs in cell-free lysates prepared from the
mouse KC cultures
Next, we developed a cell-free lysate translation system
from the primary mouse KC cultures to investigate
whether and how the PV L1 mRNAs that were in vitro
transcribed could be translated in vitro. We observed that
the PV L1 mRNAs, whether they were transcribed in vitro
from the Nat or Mod PV L1 genes, could be in vitro
translated in the KC cell-free lysates when the L1 mRNAs
were capped with m7 GpppG and the endogenous
mRNAs in the cell-free lysates were completely hydrolysed
(Figure 7). We observed further that the PV Nat L1
mRNAs could be in vitro translated in the D0 lysate, but
the translational eﬃciencies were distinctly lower than
those in the D3 and D8 lysates (Figure 7). In contrast,
although the PV Mod L1 mRNAs could be translated
in vitro both in the D0 and D8 lysates (Figure 7), the
translational eﬃciencies of the L1 proteins from the PV
Mod L1 mRNAs in the D8 lysate were dramatically
decreased (Figure 7). The data suggest that the PV Nat L1
mRNAs have the translational preference to the cell-free
lysates prepared from the diﬀerentiated mouse KC
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Figure 5. Translation of PV Nat L1 genes is preferentially enhanced by
aa-tRNA from D8 cultured mouse KCs in a rabbit reticulocyte lysate
cell-free in vitro translation system. (A) Both Nat and Mod HPV6b and
BPV1 L1 genes from were translated in a cell-free system using rabbit
reticulocyte lysate (RRL) in the presence of [35S]methionine over a time
course from 15 to 45min. Production over time of L1 protein from Nat
L1 genes (HPV6b or BPV1) is much slower than from Mod L1 genes.
(B) Supplementation of the in vitro translation reaction with aa-tRNA
from D0 or D8 cultured KC did not aﬀect L1 production from Mod
PV L1 genes at 15min. (C) Supplementation of the in vitro translation
reaction with aa-tRNA from D0 or D8 cultured KC enhances L1
production from native L1 genes in a dose-dependent manner from
108 to 106M at 15min: inhibition of translation is evident at the
highest concentrations of aa-tRNA. Upper panel: representative western
blots of three independent experiments. Lower panel: histograms
showing means ( S.E.M.) of L1 protein production from six
individual blotting assays from three independent experiments quanti-
ﬁed by use of a PhosphorImager. Statistical analysis of the results
from individual tRNA concentrations from these experiments was
conducted using paired t test. P50.01 was compared between D0 and
D8 aa-tRNA treatments as shown.
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cultures, while the PVMod L1 mRNAs prefer to translate
the L1 proteins in the cell-free lysate prepared from less-
diﬀerentiated mouse KC cultures. The results are con-
sistent with the western blot analysis of continuous
expression of the PV L1 proteins from both Mod and
Nat L1 genes in L1-transfected KCs (Figure 2B).
aa-tRNAs fromD0 and D8 mouse KC cultures differentially
enhance translation of the PVMod andNat L1 mRNAs in
KC cell-free lysate translation system
We have also examined whether additional supplementa-
tion of the aa-tRNAs (107M) prepared from D0 and D8
mouse KC cultures could enhance translation of the PV
Nat andMod L1 mRNAs in the D0 and D8 lysates in vitro
(Figure 8). Introduction of exogenous aa-tRNAs from D0
KCs only enhanced signiﬁcantly the translation of the
BPV1 Nat L1 mRNAs in the D0 KC lysate at the 2 h time
point (Figure 8A and B). In contrast, addition of
exogenous aa-tRNAs from D8 KC culture signiﬁcantly
enhanced the translation of both HPV6b and BPV1 Nat
PV L1 mRNAs in the D0 lysate at the two time points
(1 or 2 h) (Figure 8A and B). The aa-tRNAs from D0 KC
culture signiﬁcantly enhanced translation of the Mod L1
mRNAs from both HPV6b and BPV1 in D8 lysate, while
the aa-tRNAs from D8 KC culture only enhanced
translation of the BPV1 Mod L1 mRNA in D8 lysate at
the 1 h time point (Figure 8C and D). The results support
the ﬁndings for the translation of the PV L1 genes in vitro
in RRL translation system (Figures 5 and 6).
DISCUSSION
The PV life cycle is tightly linked to epithelial cell
diﬀerentiation. Translation of the virus capsid proteins
(L1 and L2) is restricted to the diﬀerentiated KCs
although a range of polycistronic mRNAs including late
open reading frames (L1 and L2 genes) can be detected in
undiﬀerentiated PV-infected KCs (35–39). Thus, diﬀerent
posttranscriptional mechanisms that likely prevent capsid
protein translation have been proposed to explain why
measurable late gene mRNAs are not associated with
production of late proteins in less diﬀerentiated cells.
First, an AU-rich element in the 3’ untranslated region of
the late gene polycistronic mRNA of several HPVs has
been reported to inhibit translation of the late genes in
undiﬀerentiated epithelial cells (13,40,41). However, a
range of strong constitutive promoters including retroviral
LTRs, CMV and SV40 have been used to construct many
authentic sequence L1 gene expression constructs from
diﬀerent HPV types in various laboratories (42,43).
These L1 expression constructs that do not contain the
inhibitory elements can easily produce the L1 transcripts
when they are transiently or stably transfected to
diﬀerent mammalian cells. But eﬃcient translation of
these authentic sequence L1 gene constructs has not
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Figure 6. Translation of PV Nat and Mod L1 genes is diﬀerentially
enhanced by aa-tRNA from D0 and D8 human KC cultures in a
rabbit reticulocyte lysate cell-free in vitro translation system.
(A) Supplementation of the in vitro translation reaction with aa-
tRNA (107M) from D0 cultured human KCs increased L1 production
from Mod PV L1 genes at 20min. (B) Supplementation of the in vitro
translation reaction with aa-tRNA (107M) from D0 or D8 cultured
KC enhances L1 production from PV Nat L1 genes at 20min. Upper
panel: representative immunoblots of two independent experiments.
Lower panel: histograms showing means ( S.E.M.) of L1 protein
production from three individual immunoblotting assays from two
independent experiments by use of a monoclonal antibody against the
L1 protein. Statistical analysis of the results from these experiments
with or without supplementation of aa-tRNAs was conducted using
paired t test. P50.01 was compared between D0 and D8 aa-tRNA
treatments as shown.
HPV 6b       BPV1 HPV 6b     BPV1 
KC lysate  D0    D3     D0   D3  D8 D8 KC lysate    D0   D8   D0   D8 
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Figure 7. Translation of PV Nat and Mod L1 mRNAs is diﬀerent
among the KC lysates from the primary mouse KCs cultured for
diﬀerent period (D0, D3 and D8). 1 mg of each of the PV L1 mRNAs
was used for the in vitro translation reaction in KC lysates. Translation
reaction was carried out at 308C for 3 h.
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been reported. Second, a splicing enhancer or silencer in
HPV genome is involved in the expression of the late
genes. A splicing enhancer in the E4 coding region of
HPV16 is required for inhibition of premature late gene
expression (44). Zhao et al. (2005) (45) reported further
that an hnRNP A1-dependent splicing silencer in the
HPV16 L1 coding region prevents premature expression
of the L1 gene. Unfortunately, whether the reported
splicing enhancer or silencer can induce protein expression
of the late genes has not been reported. Third, blockage to
translation of L1 mRNA has been attributed to sequences
within the L1 ORF (46,47). Tan et al. reported ﬁrst that
most of the sequence of L1 ORF is inhibitory for L1
translation (46) A major inhibitory element located within
the ﬁrst 129 nucleotides of the L1 gene was then reported
(47). Again, expression of L1 and L2 proteins from HPV
native L1 and L2 gene expression constructs has not been
observed in transiently transfected mammalian cells (47).
Evidently, the mechanism of the tight control of PV late
gene expression is not understood well.
Recently, by establishing mouse primary KC culture,
we were successful, for the ﬁrst time, to express the L1
proteins of two PV types (HPV6b and BPV1) by transient
transfection of authentic or codon modiﬁed L1 gene
Figure 8. Translation of PV Nat and Mod L1 mRNAs is diﬀerentially enhanced by aa-tRNAs from D0 and D8 mouse KC cultures in KC lysate
system. Supplementation with 107M aa-tRNA from D8 cultured KCs signiﬁcantly enhanced L1 protein production from native L1 mRNAs in D0
KC lysate in vitro (A and B), while the L1 protein production from modiﬁed L1 mRNAs in D8 KC lysate in vitro was signiﬁcantly enhanced by
supplementation with 107M aa-tRNA from D0 cultured KCs (C and D). Upper panel: representative western blot analysis of four blots from two
independent experiments. Lower panel: histograms showing means ( S.E.M.) of L1 signals from the four blots quantiﬁed by densitometric analysis
using the Imagequant program (Molecular Dynamics, USA). Statistical analysis of the results from these experiments at the two time points was
conducted. P50.01 and P50.05 represent the signiﬁcant degree of the diﬀerences between two treatments using t Test, respectively.
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expression plasmids (23). KC cultures are heterogeneous,
which contain two cell populations: replicating and
terminally diﬀerentiating cells (48). The terminally diﬀer-
entiating KCs that do not divide in culture progressively
proceed diﬀerentiation and increase their cell size (49).
Considering the speciﬁc characteristics of the KC cultures,
we used lipofectamine to transfect the L1 gene plasmid
DNAs to the cultured KCs at 80–90% conﬂuence instead
of 50–70% conﬂuence, which is recommended by the
manufacturer. We then used ﬂow cytometry analysis to
examine the transfection eﬃciency of the KC cultures
transfected with a GFP expression construct and observed
that 30–40% of the cultured KCs expressed GFP
(unpublished data). The L1 gene expression constructs
used in our experiments were driven by a strong
constitutive CMV promoter. Therefore, it is possible
that the levels of expression of L1 mRNA and protein in
the present experimental systems would be much higher
than those ever achieved during a real infection. It is also
clear that the claimed inhibitory elements in the L1 ORFs
are not the active inhibitors of translation of L1 mRNAs
in our previous and present studies.
In the present study, we have investigated continuous
expression patterns of PV Nat and Mod L1 genes in
cultured mouse and human KCs following a single
transfection of the L1 plasmid DNAs. Regarding expres-
sion of the PV genes in diﬀerent mammalian cells,
previous studies have reported that synonymous codon
substitution can overcome the translation blockage of
the viral capsid gene mRNAs (10) and increase levels
of E7 protein up to 100-fold due to highly eﬃcient
translation of the codon-replaced viral mRNAs (50).
A deeper understanding of the quantitative relationship
between codon usage and protein levels must include
studies on the relationship between codon usage and
mRNA levels, and subsequently also the relationship
between mRNA levels and protein productivity. Previous
studies have reported that the mRNAs of myc and fos
genes can be continuously expressed in primary cultured
KCs, irrespective of their proliferative or diﬀerentiated
state (51). However, many small vectors with heterologous
promoters are prone to vector loss and transcriptional
silencing although continuous expression of a transgene
at therapeutic levels is required for successful gene
therapy (52). Only the viral vectors containing U1
snRNA promoters may be an attractive alternative to
vectors containing viral promoters for continuous high-
level expression of therapeutic genes or proteins (53).
Therefore, we examined ﬁrst whether and how mRNAs of
the PV L1 genes, whether or not they are codon modiﬁed,
were continuously transcribed in primary KC cultures
over twelve days following a single transfection of the L1
gene expression constructs in D1 mouse and human KC
culture. Both the Nat and Mod PV L1 genes cloned into
the pCDNA3 vector were driven to express by the CMV
promoter, they exhibited continuous mRNA transcription
in mouse and human KC culture. But the levels of the
Mod PV L1 mRNAs were signiﬁcantly higher than those
of the Nat PV L1 mRNAs in the cultured KCs over the
time course investigated, irrespective of their diﬀerentia-
tion status, indicating that codon usage can improve
transcription eﬃciency of the viral genes examined in the
cultured KCs. The Mod PV L1 genes were substantially
substituted with the codons ending with G or C, exhibiting
GC manifest of their mRNA sequences because the Nat
PV L1 genes have a strong bias of using codons ending
with A or T (11). Thus, from the gene transcription
perspectives, the PV L1 genes favour the codons ending
with G or C in their gene sequences.
An interesting observation in the present study is that
the expression of the PV L1 proteins from the two
Mod PV L1 genes was scarcely detected at D9 post-
transfection. This expression pattern is distinctly diﬀerent
from that of the two Nat PV L1 genes, which showed
continuously up-regulated expression of the L1 proteins
and increased the duration of translation of their mRNAs
in both mouse and human KC cultures. It has been
reported that genes known to be expressed during latency
display codon usage strikingly diﬀerent from the
genes that are expressed during lytic growth in the
Epstein-Barr virus (54). In particular, the percentage of
codons ending with G or C is persistently lower (about
20%) in all latent genes than in non-latent genes (54).
Also, the latent genes have codon usage substantially
diﬀerent from that of host cell genes to minimize
deleterious consequences to the host of viral gene expre-
ssion during latency (54). Thus, the principal explanation
to account for the disparity of continuous expression of
the L1 proteins from Nat and Mod PV L1 genes in the
present study appears to be their synonymous codon
usage. The strong A/T codon usage bias of the Nat PV L1
genes due to natural selection may be a main determinant
for the increased duration of translation of their mRNAs
in diﬀerentiated KCs.
Codon usage bias as the main determinant of eﬃcient
mRNA translation has been observed in many genes of
Saccharomyces cerevisiae (55). In the present study, we
showed that up- and down- regulated translations of
either Nat or Mod PV L1 mRNAs in cultured mouse and
human KCs were dependent on cell diﬀerentiation.
Generally, diﬀerentiation-dependent translation of genes
is determined by interaction of regulatory mRNA
sequences with translational regulators (56). Two proteins,
hnRNPK and hnRNP E1/E2 from rabbit reticulocytes,
mediate translational silencing of cellular and viral
mRNAs in a diﬀerentiation-dependent way by binding
to speciﬁc regulatory sequences (57). Expression of
15-lipoxygenase (LOX) gene is typically regulated by a
translational regulatory process. LOX mRNA accumu-
lates early during diﬀerentiation, a diﬀerentiation control
element in its 30 untranslated regions confers translational
silencing until late stage erythropoiesis (58). The human
cytomegalovirus (HCMV) major immediate-early (MIE)
genes, encoding IE1 p72 and IE2 p86, are activated by a
complex enhancer region that operates in a cell type- and
diﬀerentiation-dependent manner (59). Enzymes that are
responsible for the translational control of gene expression
have also been observed (57,60). A novel mechanism of
translational gene regulation by which silenced mRNAs
can be translationally activated by the c-Src kinase was
reported (57). In HPV, raft cultures treated with activators
of protein kinase C can induce post-transcriptional
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changes in the late gene expression, which may occur
through inactivation or down-regulation of splicing
factors that inhibit use of the late region polyadenylation
site, resulting in increased instability of late region
transcripts (60). As discussed above, diﬀerent translational
inhibitory mechanisms have been proposed to explain the
block to PV L1 and L2 protein expression (47,61). However,
neither the ‘block’ nor the inhibitory element is incomplete
as how else would new infections/particles arise. Based on
the systematical analysis in the present study, it is evident
that the primary determinant mediating diﬀerentiation-
dependent translation of the PV L1 mRNAs in KCs is the
synonymous codon usage of the PV L1 genes, supporting
that codon-mediated translational controls may play an
important role in the diﬀerentiation and regulation of
tissue-speciﬁc gene products in humans (7).
A question arising from the present study is why the
gene codon usage can diﬀerentially turn translation
of the PV L1 genes on and oﬀ by a post-transcriptional
regulatory process. In the bacterium E. coli and in yeast,
the use of synonymous codons is strongly biased,
comprising both bias between codons recognized by the
same transfer RNA (tRNA) and bias between groups of
codons recognized by diﬀerent synonymous tRNAs.
Therefore, highly expressed genes use a subset of optimal
codons in accordance with their respective major iso-
acceptor tRNA levels (5,6). A model was developed for
the co-evolution of codon usage and tRNA abundance
explaining why there are unequal abundances of synon-
ymous tRNAs leading to biased usage between groups of
codons recognized by them in unicellular organisms (62).
Recently, a signiﬁcant correlation was found between
tRNA relative abundances and codon composition of
Buchnera genes (63). Evidently, the match between codon
usage and tRNA that mediates translational regulation is
a widely used mechanism of translational control.
However, in multicellular eukaryotes, there is limited
experimental data on tRNA abundance (64) and its
function in regulating gene expression. Although a
relationship between tRNA abundance and codon usage
in Drosophila has been reported (65), no experimental
evidence of how codon usage parallels tRNA content to
regulate gene translation has been provided. Therefore, it
is not clear how tRNA abundance in cells reﬂects the
corresponding codons in mRNAs of the target genes to
mediate mRNA translation. Recently, we have reasoned
that if the PV L1 protein production by the native L1
genes, which is blocked in less-diﬀerentiated epithelial
cells, is due to the restricted availability of the appropriate
tRNAs, the tRNA pools should be diﬀerent between
proliferative and diﬀerentiated KCs. Consequently, tRNA
proﬁles of the diﬀerentiated KCs in vivo, obtained by high
pressure liquid chromatography (HPLC) separation, were
distinct from those of undiﬀerentiated cells in vivo in
mouse and bovine (23). Meanwhile, aa-tRNAs from
diﬀerentiated mouse KCs signiﬁcantly enhanced transla-
tion of native PV L1 genes in a rabbit reticulocyte lysate
cell-free in vitro translation system (23). In the present
study, we observed that the tRNA proﬁle of D0 KCs
diﬀers from that of D8-cultured KCs using tRNA gel
electrophoresis (unpublished data). Functionally, aa-tRNAs
from D8 cultured KCs signiﬁcantly enhanced translation
of the Nat PV L1 genes or mRNAs in both RRL and D0
lysate in vitro translation systems, but only aa-tRNAs
from D0 human KC cultures signiﬁcantly enhanced
translation of the Mod PV L1 DNAs in RRL in vitro
translation system and from D0 mouse KC cultures
signiﬁcantly enhanced translation of the Mod PV L1
mRNAs in D8 cell-free lysate in vitro translation system.
Previous studies have shown that tRNAs from uninfected
cells can rescue the translation of global proteins in
Autographa californica nucleopolyhedrovirus-infected
Ld652Y cells (66). Stimulating expression of GTase with
tRNAAGA and tRNAAGG resulted in a 5-fold increase in
GTase production in E. coli in which codon usage is
highly biased and the tRNAs speciﬁc to codons AGAarg
and AGGarg are extremely rare (67). A correlation
between tRNA content constraints and gene expression
levels has been clearly demonstrated using the concept of
optimal codons (68). Here, the inability to express PV L1
protein from the native L1 gene sequence in undiﬀer-
entiated KCs and from modiﬁed L1 gene sequence in
diﬀerentiated KCs appears to be due to availability of the
cellular tRNAs. Native PV L1 mRNAs may translate in
undiﬀerentiated KC lysate in which endogenous mRNAs
(host mRNAs) were completely hydrolysed, which may
have evolved to exploit the tRNA resources available for
their eﬃcient translation in diﬀerentiated KCs. The
argument is strongly supported by our early work that
showed that the problem of translation blockage of PV L1
genes in non-diﬀerentiated mammalian cells can be
alleviated by gene codon modiﬁcation (10) or by cellular
tRNA population alteration (17).
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